The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, November 05, 2020
Therapeutics Solutions announced the filing of a patent application covering novel findings demonstrating enhancement of blood brain barrier integrity...
read more
Thursday, November 05, 2020
reVision announced the FDA has granted the Company's request to designate REV-0100 as an Orphan-Drug and a Rare Pediatric Disease Drug for Stargardt ...
read more
Thursday, November 05, 2020
Novartis and Molecular Partners announced an option and license agreement to develop, manufacture and commercialize DARPin program.
read more
Thursday, November 05, 2020
Qualigen announced written feedback to its Type B Pre-IND meeting request from the FDA that is in general agreement with the Company's planned ...
read more
Thursday, November 05, 2020
Orasis announced the initiation of Phase 3 clinical studies in the U.S., evaluating its novel eye drop candidate designed to improve near vision for ...
read more
Friday, November 06, 2020
Regeneron announced positive, prospective results from an ongoing Phase 2/3 seamless trial in the COVID-19 outpatient setting.
read more
Friday, November 06, 2020
OncoSec Medical announced the FDA has approved the IND application for a first-in-human Phase 1 trial for CORVax12, a novel DNA-encodable vaccine ...
read more
Tuesday, November 10, 2020
Pfizer and BioNTech announced their vaccine candidate against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants ...
read more
Tuesday, November 10, 2020
The FDA granted EUA for Eli Lilly and Company's investigational neutralizing antibody bamlanivimab.
read more
Tuesday, November 10, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Tuesday, November 10, 2020
Rafael announced the FDA granted Orphan Drug Designation for CPI-613 for the treatment of soft tissue sarcoma.
read more
Tuesday, November 10, 2020
BioLineRx announced positive results from a planned interim analysis of the ongoing GENESIS Phase 3 trial of motixafortide for stem cell mobilization ...
read more
Tuesday, November 10, 2020
AIVITA Biomedical announced treatment has been completed for all 57 patients in the Phase 2 clinical trial of AV-GBM-1 in patients with glioblastoma.
read more
Wednesday, November 11, 2020
Senhwa Biosciences has submitted an IND application with the FDA to evaluate Silmitasertib for severe COVID-19.
read more
Wednesday, November 11, 2020
Enlivex Therapeutics reported the Israeli Ministry of Health authorized the initiation of a proposed Company-sponsored Phase IIb clinical trial ...
read more